Medical News

RSS

Relevare Pharmaceuticals to present CNSB015 Phase IIa results at international neuropathic pain congress

Relevare Pharmaceuticals Ltd. will present its recent Phase IIa proof-of-concept clinical trial data and extension study results for CNSB015 (flupirtine), its lead repositioned compound, at the Third International Congress on Neuropathic Pain on May 27 –30 in Athens, Greece.

28 May 2010

Fire safety experts announce statewide program to prevent camp fire injuries, forest fires

Accompanied by Smokey the Bear, burn and fire safety experts today announced a statewide program to prevent camp fire injuries and forest fires. The median age of camp fire victims is two years old and many injuries happen long after the fire is thought to be extinguished. Experts say most of the incidents are predictable and preventable.

28 May 2010

PuriCore sales decreases 9.9% to $10.0 million for first-quarter 2010

PuriCore, the water-based clean technology company focused on developing and commercializing proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens, today issued its Interim Management Statement covering the period January 1, 2010, to March 31, 2010.

28 May 2010

VIVUS to present phase 3 data on avanafil for treatment of ED at AUA 2010

VIVUS, Inc. today announced that phase 3 data on avanafil, a next generation oral phosphodiesterase type 5 inhibitor therapy being investigated for the treatment of erectile dysfunction, will be presented next Tuesday at the American Urological Association 2010 Annual Meeting in San Francisco, California.

28 May 2010

Advanced Life Sciences expands partnership with U.S. Government to assess Restanza against STI's

Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced the expansion of its collaboration with the U.S. Government to include the evaluation of Restanza's activity against sexually transmitted infections (STI's), such as gonorrhea.

28 May 2010

Healthy Returns Initiative developed to address health issues in California's juvenile justice system

The California Endowment issued a report today highlighting the results of a four year initiative created to strengthen the capacity of county juvenile justice systems to provide mental health and other needed services for youth while in custody and in the community.

28 May 2010

PuriCore revenue increases 28% to $40.0 million for year ending December 31, 2009

PuriCore, the water-based clean technology company focused on developing and commercializing proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens, today announced its Final Results for the year ending December 31, 2009, and the availability of its 2009 annual report on its website.

28 May 2010

KCI receives 510(k) clearance to market V.A.C. Therapy System for treatment of VLUs

Kinetic Concepts, Inc. announced today that it has received 510(k) clearance from the Food and Drug Administration to market its proprietary Vacuum Assisted Closure, or V.A.C. Therapy System, for the treatment of venous insufficiency ulcers, also known as venous leg ulcers.

28 May 2010

Amorfix, Aragen Bioscience collaborate to develop high-affinity monoclonal antibodies against targets for cancer

Amorfix Life Sciences and Aragen Bioscience, Inc. announced today that they have entered into an agreement to develop high-affinity monoclonal antibodies against a number of targets for cancer. Using its proprietary ProMIS(TM) computational platform discovery technology, Amorfix has identified several disease specific epitopes ("DSEs") on misfolded Fas receptor. Aragen will use those DSEs to generate highly specific monoclonal antibodies ("mAbs").

28 May 2010

Advocates urge Congress to reauthorize C.W. Bill Young Cell Transplantation Program and NCBI

More than 60 adult donors, transplant recipients, family members and medical professionals from 25 states met with lawmakers and staff on Capitol Hill today to urge Congress for increased federal funding to grow and diversify the national registry of adult donors and publicly available cord blood units as part of the C.W. Bill Young Transplantation Program and the National Cord Blood Inventory.

28 May 2010

Effective infant vaccination against pneumonia needed in sub-Saharan Africa

Researchers at the University of Warwick, and the Kenya Medical Research Institute, Kilifi, Kenya, have found that respiratory syncytial virus (RSV) appears to be the predominant virus detected among infants and children hospitalized in Kenya with severe pneumonia, according to a study in the May 26 issue of JAMA. The contribution to this severe disease by an individual pathogen stresses the need for effective infant vaccination.

28 May 2010

VIVUS first-quarter 2010 total revenues decline: MicroStockProfit.com

MicroStockProfit.com announces an investment report featuring VIVUS Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

28 May 2010

Nymox Pharmaceutical announces symposium and panel discussion on NX-1207 drug for BPH

Nymox Pharmaceutical Corporation is pleased to announce the presenters and participants for the symposium and panel discussion on NX-1207, the Company's Phase 3 drug for benign prostatic hyperplasia (BPH), to be held during the 2010 Annual Meeting of the American Urological Association in San Francisco at 3:00 p.m. June 1.

28 May 2010

DaVita provides hurricane hotline to help dialysis patients find clinics, schedule treatments during emergencies

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease, announced today that the company will provide a hurricane hotline (1-800-400-8331) that is activated 24 hours a day, seven days a week to help dialysis patients find open clinics and schedule treatments during emergencies such as hurricanes and other natural disasters.

28 May 2010

Researchers see plectasin as promising lead compound for new antibiotics

An active compound from fungi and lower animals may well be suitable as an effective weapon against dangerous bacteria. We're talking about plectasin, a small protein molecule that can even destroy highly resistant bacteria . Researchers at the Universities of Bonn, Utrecht, Aalborg and of the Danish company Novozymes AS have shed light on how the substance does this.

28 May 2010

MicroStockProfit.com releases investment report on Cord Blood America

MicroStockProfit.com announces an investment report featuring Cord Blood America Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

28 May 2010

SAP selects ResearchPoint as Showcase company for Business ByDesign product

ResearchPoint is proud to announce that it has been selected as a Showcase® company by SAP for its use of their product, Business ByDesign. The company began implementation of the solution 11 months ago and continues to collaborate with SAP on the development of this SaaS (software as a service, also known as on-demand) offering for the small and mid company market.

28 May 2010

Infectious diseases specialist from Walter and Eliza Hall Institute receives Frank Fenner Award

Infectious diseases specialist Dr Marc Pellegrini from the Walter and Eliza Hall Institute will today receive the Frank Fenner Award from the Australasian Society for Infectious Diseases, recognising Dr Pellegrini's efforts to understand human responses to chronic infections.

28 May 2010

CrystalGenomics to merge with BexPharm

CrystalGenomics, Inc., a leading biopharmaceutical company developing novel small molecule therapeutics announced today that it will merge with BexPharm, a specialty pharmaceutical company that imports and distributes foreign market approved drugs in Korea.

28 May 2010

LCA commends Senator Snowe, Congresswoman Pingree for support of Lung Cancer Mortality Reduction Act

Today, Lung Cancer Alliance (LCA) commended Senator Olympia Snowe (R-ME) and Congresswoman Chellie Pingree (D-ME) for joining Congressman Michael Michaud (D-ME) as cosponsors of the Lung Cancer Mortality Reduction Act (LCMRA), a bi-partisan, bi-cameral bill that establishes the first ever multi-agency, comprehensive research program targeting all aspects of lung cancer.

28 May 2010

Medical News

Relevare Pharmaceuticals to present CNSB015 Phase IIa results at international neuropathic pain congress

Fire safety experts announce statewide program to prevent camp fire injuries, forest fires

PuriCore sales decreases 9.9% to $10.0 million for first-quarter 2010

VIVUS to present phase 3 data on avanafil for treatment of ED at AUA 2010

Advanced Life Sciences expands partnership with U.S. Government to assess Restanza against STI's

Healthy Returns Initiative developed to address health issues in California's juvenile justice system

PuriCore revenue increases 28% to $40.0 million for year ending December 31, 2009

KCI receives 510(k) clearance to market V.A.C. Therapy System for treatment of VLUs

Amorfix, Aragen Bioscience collaborate to develop high-affinity monoclonal antibodies against targets for cancer

Advocates urge Congress to reauthorize C.W. Bill Young Cell Transplantation Program and NCBI

Effective infant vaccination against pneumonia needed in sub-Saharan Africa

VIVUS first-quarter 2010 total revenues decline: MicroStockProfit.com

Nymox Pharmaceutical announces symposium and panel discussion on NX-1207 drug for BPH

DaVita provides hurricane hotline to help dialysis patients find clinics, schedule treatments during emergencies

Researchers see plectasin as promising lead compound for new antibiotics

MicroStockProfit.com releases investment report on Cord Blood America

SAP selects ResearchPoint as Showcase company for Business ByDesign product

Infectious diseases specialist from Walter and Eliza Hall Institute receives Frank Fenner Award

CrystalGenomics to merge with BexPharm

LCA commends Senator Snowe, Congresswoman Pingree for support of Lung Cancer Mortality Reduction Act

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News